XML 13 R7.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income $ 27,918 $ 32,966
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 558 699
Net amortization of investments 847 1,872
Change in investment related allowance for credit losses (33) (35)
Deferred income taxes (750) (1,102)
Net realized (gains) losses on investments 339 (333)
Net unrealized gains on equity securities (4,718) (3,417)
Net realized losses on disposal of assets 209 2
Share-based compensation 1,398 646
Changes in operating assets and liabilities:    
Premiums receivable, net (20,454) (18,666)
Accrued interest receivable 98 41
Deferred policy acquisition costs (1,531) (1,526)
Other assets (1,648) (180)
Reserves for loss and loss adjustment expenses (10,009) (11,424)
Unearned premiums 11,470 11,268
Reinsurance balances 5,722 2,585
Amounts held for others and policyholder deposits (5,646) 2,750
Federal income taxes recoverable 226 3,754
Accounts payable and other liabilities 918 843
Net cash provided by operating activities 4,914 20,743
Investing activities    
Purchases of investments held-to-maturity (5,465) (9,596)
Purchases of investments available-for-sale (6,639) (38,107)
Purchases of short-term investments (46,957) (46,347)
Proceeds from maturities of investments held-to-maturity 22,393 24,488
Proceeds from sales and maturities of investments available-for-sale 35,313 20,818
Proceeds from sales of equity securities 7,933 262
Proceeds from sales and maturities of short-term investments 0 14,175
Purchases of property and equipment (802) (37)
Net cash provided by (used in) investing activities 5,776 (34,344)
Financing activities    
Finance lease purchases (42) (47)
Share-based compensation related tax withholding (429) (779)
Purchase of treasury stock (4,113) 0
Dividends to shareholders (14,177) (13,120)
Net cash used in financing activities (18,761) (13,946)
Change in cash and cash equivalents (8,071) (27,547)
Cash and cash equivalents at beginning of period 38,682 61,469
Cash and cash equivalents at end of period $ 30,611 $ 33,922